CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 95 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $9,955,000 | -50.0% | 292,292 | -43.3% | 0.12% | -39.9% |
Q4 2021 | $19,918,000 | -33.1% | 515,489 | -6.5% | 0.20% | -42.5% |
Q3 2021 | $29,752,000 | +52.0% | 551,065 | -5.9% | 0.35% | +36.3% |
Q2 2021 | $19,573,000 | +172.4% | 585,311 | +67.8% | 0.26% | +144.3% |
Q1 2021 | $7,186,000 | +4.3% | 348,840 | -11.3% | 0.11% | -4.5% |
Q4 2020 | $6,889,000 | +15.6% | 393,215 | -2.1% | 0.11% | -9.0% |
Q3 2020 | $5,958,000 | – | 401,763 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |